Add to the list of shuttle systems is the Nanostructured Lipid carrier system (NLC). In contrast to Moderna and Pfizer's Lipid Nanoparticle System (LNP), the RNA here is attached outside the lipid system. By this, the RNA can be replaced much more easily in case of mutation and needs no deep freezing. ImmunityBio does have an ongoing clinical trial, and the system is developed in collaboration with the Advanced Health Institute.
Add to the list of shuttle systems is the Nanostructured Lipid carrier system (NLC). In contrast to Moderna and Pfizer's Lipid Nanoparticle System (LNP), the RNA here is attached outside the lipid system. By this, the RNA can be replaced much more easily in case of mutation and needs no deep freezing. ImmunityBio does have an ongoing clinical trial, and the system is developed in collaboration with the Advanced Health Institute.